Written and maintained by CASRAI Editorial Board
Last updated
Cardiac puncture in mice is a terminal, non-recovery blood collection technique: the needle is introduced directly into the heart to draw a large blood volume in a single sample, and the animal does not survive the procedure. Institutional Animal Care and Use Committees (IACUCs) treat it as a distinct category from every other rodent bleeding route because it is classified alongside decapitation as a non-survival method, not a repeatable sampling technique — a distinction that governs the anesthesia standard, the volume that can be justified, and what the IACUC protocol must specify before the procedure is approved.
This page covers the compliance framework around cardiac puncture in mice: why it is restricted to terminal procedures, the anesthetic depth confirmation required beforehand, the blood volume reasoning that separates it from survival techniques, the standard alternatives when the study needs the animal to live, and what an IACUC protocol document must contain to authorize any of it. It does not walk through hand position or needle angle — that instruction belongs in a supervised, hands-on training session with the attending veterinarian or a designated trainer, per the personnel-competency requirement described below, not in a web page.
Why Cardiac Puncture Is a Terminal-Only Procedure
Cardiac puncture is not survivable as a matter of practice, and IACUCs do not approve it as one. Puncturing the ventricle carries a high risk of cardiac tamponade, hemothorax, or fatal arrhythmia even when performed correctly, and the volume typically drawn (see below) exceeds what a mouse can safely lose and continue circulating. The Guide for the Care and Use of Laboratory Animals, 8th edition, and AVMA guidance on euthanasia adjuncts both treat exsanguination-by-cardiac-puncture the same way: it is acceptable only when performed on an animal that is already unconscious under a surgical plane of anesthesia, immediately followed by confirmation of death by a physical method (cervical dislocation, decapitation, or a second confirmatory sign such as absence of heartbeat/respiration), because the blood loss and cardiac injury alone are not always immediately fatal on their own timeline. This is the same logic that governs decapitation and other non-recovery adjuncts: the technique is not itself the euthanasia method, anesthesia is, and the technique confirms death rather than causing it independently.
Because of this, cardiac puncture in mice is only ever justified in a protocol as an end-of-study procedure — typically to obtain a maximal terminal blood or serum volume for assays that need more material than a survival draw can provide, performed at the same time as euthanasia rather than as a stand-alone sampling event.
Confirming Anesthetic Depth Before the Procedure
Because cardiac puncture is performed on a live, anesthetized animal rather than a euthanized one, confirming an adequate anesthetic plane immediately beforehand is the safety-critical step in the protocol, not an optional precaution. Standard practice requires confirming absence of the pedal withdrawal (toe-pinch) reflex and, often, the corneal reflex, plus stable respiratory pattern consistent with a surgical plane, before the needle is introduced — the same depth confirmation required before any other invasive terminal procedure. A mouse that responds to a toe pinch is not adequately anesthetized for cardiac puncture, full stop; the procedure does not proceed until that reflex is absent. This is why the IACUC protocol must name the anesthetic agent, route, and dose, and describe exactly how depth will be confirmed, rather than simply stating that the animal “will be anesthetized.”
Confirmation does not stop at the moment of puncture. Because cardiac puncture and exsanguination are adjuncts to euthanasia rather than euthanasia methods in themselves, the protocol must also specify a secondary physical method to confirm death after the procedure — the same requirement that applies whenever an anesthetic overdose or exsanguination is used as the primary method. Institutions vary in which secondary method they require (cervical dislocation, decapitation, or bilateral thoracotomy are all standard), but the requirement that one be documented is consistent across AVMA-aligned institutional policy.
Blood Volume: Why a Terminal Draw Can Take More
The reason cardiac puncture is grouped with terminal procedures rather than survival bleeding routes is directly tied to volume. A mouse’s total circulating blood volume is roughly 6–8% of its body weight, so a 25 g mouse carries on the order of 1.5–2 mL of blood in total. Widely used lab-animal-science guidance on blood sampling volumes (e.g., Diehl et al., “A good practice guide to the administration of substances and removal of blood, including routes and volumes,” Journal of Applied Toxicology, 2001, still the standard reference cited in institutional SOPs) caps a single survival sample at roughly 1% of body weight (about 7–10% of total blood volume) with weeks of recovery before a repeat draw, or a somewhat higher per-draw ceiling if sampling is infrequent and veterinary-approved. A terminal cardiac puncture, by contrast, can draw a substantially larger fraction of total blood volume — commonly cited as up to roughly half of circulating volume or more — specifically because the animal is not expected to recover circulatory function afterward. That gap in permissible volume is the practical reason a study that needs a large serum or plasma yield reaches for cardiac puncture as an end-of-study procedure rather than scaling up a survival technique past its safe limit.
An IACUC reviewing a protocol that requests cardiac puncture will specifically check that the requested volume is consistent with a terminal draw and that the protocol does not describe it as repeatable — a proposal to cardiac-puncture the same animal on more than one occasion is a standard-practice red flag reviewers are trained to catch.
Alternatives for Survival Blood Collection
When a study design needs serial samples from the same animal — a pharmacokinetic time course, a longitudinal biomarker study — cardiac puncture is the wrong tool regardless of assay volume needs, because the animal must survive to the next timepoint. Three routes cover the great majority of survival bleeding in mice, each with a different volume/frequency/skill profile:
| Route | Typical yield | Anesthesia | Notes |
|---|---|---|---|
| Submandibular (facial vein) | Up to roughly 1% body weight per draw | Often performed unanesthetized with proper restraint, or brief anesthesia per institutional SOP | Fast, widely used for serial sampling; requires trained restraint technique to avoid excessive pressure/hematoma |
| Tail vein (lateral tail vein) | Small volumes, lower per-draw yield than submandibular | Usually unanesthetized with warming to dilate the vessel, or brief anesthesia | Good for frequent small-volume sampling; tail vasculature can be harder to access repeatedly in some strains |
| Saphenous vein | Comparable to tail vein | Brief restraint, often unanesthetized | Useful when tail access is compromised (e.g., prior tail-vein injections in the same study) |
None of these three is a drop-in substitute for cardiac puncture when the study genuinely needs a large terminal volume — they exist to solve the opposite problem, repeated small-volume access with animal survival, and an IACUC will expect the protocol’s method-selection rationale to reflect that distinction rather than picking cardiac puncture by default because it is the largest-yield option. The same justification logic applies to other terminal-adjacent techniques on this site, such as retro-orbital injection, where survivability and technical skill requirements likewise drive which route is appropriate for a given study design.
What an IACUC Protocol Must Specify
Under 9 CFR 2.31(e), a protocol involving cardiac puncture must include, at minimum: the species and number of animals, a scientific rationale for why this route and volume are necessary (not simply that it yields more material), a complete description of the procedure including anesthesia, and the method used to confirm death. In practice, reviewers expect several specific elements spelled out for a procedure in this risk category:
- Personnel training and competency verification. Who is authorized to perform cardiac puncture, and how their competency was verified — typically supervised practice with the attending veterinarian or a designated trainer before independent performance is authorized, consistent with the personnel-qualification requirements covered in this site’s IACUC training guide.
- Anesthetic agent, dose, route, and depth-monitoring method. Not just “anesthetized” but the specific agent (e.g., isoflurane or an injectable combination), and exactly what reflex/physiologic check confirms adequate depth before the needle is introduced.
- Euthanasia confirmation method. The secondary physical method used to confirm death after cardiac puncture, since exsanguination alone is not always instantaneous.
- Justification for volume and for terminal (vs. survival) collection. Why the assay requires the volume only a terminal draw can provide, tying back to the 3Rs framing below.
- Humane endpoints and monitoring, if the procedure is not the animal’s first manipulation that day. Where cardiac puncture follows another procedure in the same terminal session, the protocol should describe monitoring up to that point.
The broader structure of what a protocol document needs — species justification, alternatives search, review pathway — is covered in depth in this site’s guides on the IACUC protocol itself and on IACUC and animal research oversight generally; this page focuses on the procedure-specific content a reviewer will look for when cardiac puncture is the requested technique. Personnel working with research animals also fall under an institutional occupational health program, separate from the didactic training requirement, since needle-based procedures on live animals carry occupational sharps-injury and allergen-exposure risk that OHS programs are designed to screen for.
3Rs and ARRIVE 2.0 Considerations
The 3Rs apply to a cardiac-puncture protocol in two directions rather than one. Refinement is the anesthesia-depth and technique standard described above — performing the procedure only under a confirmed adequate plane, by a trained individual, minimizes pain and distress even though the animal will not recover. Reduction often runs the other way: because a terminal cardiac puncture can yield enough serum or plasma for several assays from a single animal, appropriately planning which endpoints are collected from the same terminal sample can reduce the total number of animals needed compared with running separate cohorts for each assay — a genuine reduction argument, not just a volume convenience, and one reviewers will look for in the protocol’s animal-number justification.
Where cardiac puncture feeds into a study’s primary outcome measures (e.g., a terminal biomarker readout compared across treatment groups), ARRIVE 2.0‘s reporting items on blinding and randomization are relevant to how the collection itself is conducted and documented: whether the person performing or processing the terminal sample was blinded to group allocation, and whether collection order was randomized across groups rather than processed cohort-by-cohort, both affect whether a downstream result can be trusted as free of observer or order bias. A protocol and its eventual manuscript should describe both, even for a procedure that is otherwise purely mechanical.
Frequently Asked Questions
Is cardiac puncture ever performed as a survival procedure in mice?
No. Standard veterinary and institutional guidance treats cardiac puncture in mice as a non-recovery, terminal procedure only, performed under a confirmed surgical plane of anesthesia and followed by a secondary physical confirmation of death. It is not approved as a repeatable sampling route.
How much blood can be collected by terminal cardiac puncture in a mouse?
Because the animal does not need to survive, a terminal cardiac puncture can draw a substantially larger fraction of total circulating blood volume than a survival sample — commonly cited guidance puts safe survival draws at roughly 1% of body weight per sample versus a much larger terminal ceiling. The exact volume an IACUC will approve depends on institutional policy and the veterinary staff’s sign-off, and should be specified as a numeric target in the protocol rather than left open-ended.
What’s the difference between cardiac puncture and retro-orbital bleeding?
Retro-orbital bleeding can be performed as a survival procedure under general anesthesia when properly justified, though many institutions restrict it or require specific justification over alternatives — see this site’s guide on retro-orbital injection in mice for that justification standard. Cardiac puncture is categorically terminal and is not offered as a survival option.
Does the person performing cardiac puncture need specific training beyond general animal-handling competency?
Yes. Because of the technical difficulty and welfare risk if performed incorrectly (including on an inadequately anesthetized animal), IACUCs expect documented, procedure-specific training and competency verification for cardiac puncture specifically, not just general species-handling training. See this site’s IACUC training guide for how personnel qualification is typically documented and reviewed.
Can cardiac puncture be combined with other terminal procedures in the same animal?
Often, yes — a terminal cardiac puncture is frequently performed as part of a broader terminal procedure (e.g., alongside tissue collection at necropsy), and doing so can support the Reduction principle of the 3Rs by obtaining multiple endpoints from one animal. The protocol should describe the full sequence and confirm the anesthesia plane covers every step, not just the blood draw.
